Stock listing
Palisade Bio, Inc.
Selected listing: A4098S · LS · EUR · DE
Palisade Bio, Inc. (Lang & Schwarz: A4098S), Health Technology. Latest release Sep 28, 2026: Palisade Bio to Present Clinical and Translational Data…
- Ticker
- Lang & Schwarz: A4098S
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Palisade Bio, Inc.
The company focuses on developing innovative therapies to improve patient outcomes. Palisade Bio is committed to advancing its pipeline of products aimed at addressing unmet medical needs.
Latest news from Palisade Bio, Inc.
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
September 28, 2026
Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
September 23, 2026
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn’s Disease, Expanding Phase 2 Development Across IBD
September 22, 2026
Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
September 21, 2026
Palisade Bio to Participate in Upcoming Investor Conferences
September 3, 2026
Research Palisade Bio, Inc.
Alternate listings
PALI:NASDAQ
US · USD
Alternate listing for Palisade Bio, Inc.; the primary context on this page is A4098S:LS.
PALI:BOATS
US · USD
Alternate listing for Palisade Bio, Inc.; the primary context on this page is A4098S:LS.
7NS0:GETTEX
DE · EUR
Alternate listing for Palisade Bio, Inc.; the primary context on this page is A4098S:LS.
7NS0:FWB
DE · EUR
Alternate listing for Palisade Bio, Inc.; the primary context on this page is A4098S:LS.
7NS0:MUN
DE · EUR
Alternate listing for Palisade Bio, Inc.; the primary context on this page is A4098S:LS.